Literature DB >> 1737433

Peritoneal mesothelioma: the role of computed tomography in diagnosis and follow up.

P J Guest1, R H Reznek, D Selleslag, R Geraghty, M Slevin.   

Abstract

Computed tomography (CT) was performed on 15 patients with proven peritoneal mesothelioma. Eight of these patients underwent follow-up CT. It was found that a discrete and measurable mass is unusual in comparison with the common occurrence of ascites and that therefore CT has little role in quantifying the disease. Ascites is usually a prominent feature. Other features (e.g. omental infiltration) were evaluated and these could be used to assess disease progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737433     DOI: 10.1016/s0009-9260(05)80059-5

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  6 in total

1.  Malignant peritoneal mesothelioma.

Authors:  Stine Munkholm-Larsen; Christopher Q Cao; Tristan D Yan
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Role of PET imaging in peritoneal involvement of subcutaneous panniculitis-like T-cell lymphoma.

Authors:  Darren Yak Leong Chan; Nicholas Francis Grigoropoulos; Amos Zhi En Tay; Wanying Xie
Journal:  J Radiol Case Rep       Date:  2022-06-30

3.  Malignant peritoneal mesothelioma: marked variability of CT findings.

Authors:  T R Smith
Journal:  Abdom Imaging       Date:  1994 Jan-Feb

4.  CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature.

Authors:  Mahmut Kebapci; Eser Vardareli; Baki Adapinar; Mustafa Acikalin
Journal:  Eur Radiol       Date:  2003-03-25       Impact factor: 5.315

Review 5.  CT, MRI and PET imaging in peritoneal malignancy.

Authors:  Chirag M Patel; Anju Sahdev; Rodney H Reznek
Journal:  Cancer Imaging       Date:  2011-08-24       Impact factor: 3.909

6.  Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis.

Authors:  Joon Ho Cho; Seung Soo Kim
Journal:  J Belg Soc Radiol       Date:  2020-01-30       Impact factor: 1.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.